Specialist Reliefs
Research and Development Allowances
Research and Development Allowances (RDAs) refer to a specialised capital allowance regime under the Capital Allowances Act 2001 that permits businesses to claim 100% first-year tax relief on capital expenditure incurred on research and development related to their trade. RDAs accelerate tax relief for capital assets, such as laboratories, specialised testing facilities, and scientific equipment, that are used directly for R&D activities. Administered by HM Revenue and Customs (HMRC), the relief enables companies to write off the entire cost of qualifying capital assets against taxable profits in the period the expenditure is incurred. Unlike standard plant and machinery pools, RDAs provide immediate full expensing for capital items tied to scientific research, reducing the net cost of innovation infrastructure for commercial property owners and corporate taxpayers.
Why it matters
Research and Development Allowances are critical for capital-intensive industries seeking to optimise their corporate tax position while investing in state-of-the-art innovation infrastructure. By offering a 100% first-year deduction on qualifying capital expenditure, RDAs significantly improve cash flow compared to standard writing down allowances governed by the Capital Allowances Act 2001. According to HMRC tax statistics, billions of pounds in capital allowances go unclaimed annually due to complexities in distinguishing between general property improvements and specialised R&D assets. For commercial property developers and corporate occupiers constructing or refurbishing technical facilities, failing to identify RDA-eligible expenditure results in delayed tax relief and higher effective capital costs. Properly using RDAs reduces the payback period for capital investments in laboratories and R&D hubs, directly impacting a company's post-tax return on investment and encouraging domestic technological development.
The common misconception
Misconception: Any capital expenditure incurred by a company that qualifies for R&D tax credits automatically qualifies for Research and Development Allowances. Reality: R&D tax credits operate under separate legislation for revenue expenditure, whereas RDAs apply strictly to capital expenditure governed by Part 6 of the Capital Allowances Act 2001, requiring distinct eligibility criteria. Misconception: Buildings used for general office administration alongside R&D can have their entire construction cost claimed under RDAs. Reality: RDA claims on buildings are restricted strictly to structures or parts of structures used directly for the carrying out of qualifying research and development, excluding general office or retail spaces. Misconception: Claiming RDAs permanently precludes a company from claiming standard Plant and Machinery Allowances on any other building assets. Reality: Taxpayers can concurrently claim appropriate capital allowances across different asset classes, provided the same expenditure is not claimed twice under multiple regimes.
A worked example
Consider a biotechnology firm constructing a new £5 million research facility in the UK, comprising £3.5 million for the core laboratory structure and specialised ventilation, and £1.5 million for standard office fit-outs and general amenities. Without specialised capital allowance analysis, the entire development might incorrectly be lumped into the Structures and Buildings Allowance pool, yielding a slow 3% annual write-down. By engaging a specialist capital allowances tax adviser, the firm conducts a detailed forensic review aligned with HMRC guidelines. The review identifies that £3 million of the laboratory fit-out qualifies entirely for Research and Development Allowances, allowing the company to claim a 100% first-year deduction on that portion against its corporation tax liability. The remaining £500,000 of specialised plant qualifies for Full Expensing or the Main Pool, while the standard office space falls under the Structures and Buildings Allowance. This targeted allocation accelerates £3 million of tax relief into year one, generating an immediate corporation tax saving of £750,000 at a 25% tax rate, dramatically improving the project's initial cash flow.
Source: www.gov.uk